
Erin Turoff
Managing Partner
Fund formation and operations. Career in New York fund management, later COO and Managing Director of First Capital Ventures and founder of E2T2, LLC.
Investor deck
Read it here, or save the full deck as a PDF. Full economics and offering documents are shared directly with qualified investors.
Metabolic health · Brain longevity · Human performance
Metabolic Edge Fund · 01
An independent venture platform backing the companies that resolve root causes — across metabolic health, brain longevity and human performance.
Thesis
Metabolic Edge Fund · 02
Edge
Metabolic Edge Fund · 03
We back founders resolving the underlying biology rather than managing symptoms indefinitely.
Independent trials, academic collaboration and exhaustive diligence sit ahead of every commitment.
No legacy incumbent affiliations — conviction underwritten on our own work.
Sectors
Metabolic Edge Fund · 04
Brain fitness, gut-brain axis, brain-computer interfaces and EEG.
Wearables and AI turning metabolic signals into intervention.
Cellular inflammation, mitochondrial health, bioavailability.
Neuroinflammation, perfusion, neuroplasticity, sleep architecture.
Assessment and therapy without incision or ionizing radiation.
Structure
Metabolic Edge Fund · 05
Full economics, allocation policy and lifecycle detail are shared with qualified investors under the final offering documents. All terms are indicative until then.
Timeline
Metabolic Edge Fund · 06
Vehicle established, service providers appointed and offering documents finalised.
Institutional and family office anchors onboarded; pipeline diligence already underway.
Concentrated commitments across metabolic health, brain longevity and human performance.
Follow-on reserves deployed into companies clearing clinical and commercial milestones.
Staged realisations and distributions through the defined wind-down period.
Phases are sequential rather than calendar-bound. Dated milestones are confirmed with qualified investors in the final offering documents.
Partners
Metabolic Edge Fund · 07

Managing Partner
Fund formation and operations. Career in New York fund management, later COO and Managing Director of First Capital Ventures and founder of E2T2, LLC.

Managing Partner
Molecular biologist and data scientist. Founder and CEO of BRAIN.ONE, an AI-powered brain fitness and longevity platform built on biometric and behavioral analytics.
Team
Metabolic Edge Fund · 08
A deliberately lean partnership, extended by specialists brought in where a given opportunity demands them.
Partner-led sourcing with scientific diligence run alongside clinical and academic collaborators.
Metabolic, neuroscience and device specialists convened per opportunity rather than kept on retainer.
Hands-on help with clinical study design, regulatory pathway and commercial partnerships.
Independent fund administration, audit and counsel engaged outside the management company.
Affiliations
Metabolic Edge Fund · 09
Shown as wordmarks. Send official logo files and they will be dropped in directly.
Contact
Metabolic Edge Fund · 10
Institutional and family office capital only. Request access on the site and a managing partner will follow up directly with the full materials.
Metabolic Edge Fund, LLC. For qualified institutional investors only. This document is informational and is not an offer to sell or a solicitation to buy any security.
